Hormone Depletion and
Risk of Alzheimer’s Disease
It is estimated that nearly 500,000
cases of Alzheimer’s (AD) will be diagnosed this year, approximately one every
69 seconds. As we all know, AD preferentially attacks older folks. Fourteen
percent of all people aged 71 and older have dementia. But 71 is not very old
these days. So many people in their 70s and even 80s are active physically and
mentally and are enjoying life with family and leisure activities. Yet one in
six women and one in ten men aged 55 and older will be demented at some time in
their life.
It’s not a coincidence that
Alzheimer’s risk increases with age while hormone levels decline with age. Is
there a link? The biochemistry behind the development of AD certainly supports
a very strong and direct link. Testosterone, estradiol, progesterone, DHEA and
melatonin are all hormones that decline with age, yet play a critical part in
protecting the brain from the ravages of memory loss, brain cell loss and the
pathologic processes of AD itself. I don’t have time to cover all these today
but I can start with testosterone and try to cover the others soon.
Testosterone is, of course,
designated a male hormone but plays a crucial role in life for women as well.
Women have only about 10% as much testosterone as men but that 10% is important
for many functions, including brain power! Here are just a few pieces of
evidence.
In population studies of normal men, those with higher testosterone
levels were shown to have better cognitive function than those with lower
levels.1,2
In clinical trials of testosterone replacement, normal aging men with
testosterone levels at the lower end of the normal range experienced
improvements in both verbal and spatial memory when the level was raised to the
upper normal range.3
But how about men with Alzheimer’s? Well, testosterone replacement was
also very effective in improving both verbal and spatial memory in a study of
men with either Alzheimer’s or mild cognitive impairment (pre-Alzheimer’s).4
One of the two hallmarks of AD is the accumulation of beta amyloid
protein, forming plaques in the AD brain.
Testosterone influences brain levels of beta amyloid through two other
hormones: dihydrotestosterone (DHT) and estradiol (a female hormone). Some of
the testosterone in both men and women is converted by the body into these
other two hormones. So the more testosterone we have, the more DHT and
estradiol our bodies can make. Both DHT and estradiol influence brain beta
amyloid by stimulating the activity of an enzyme called neprilysin.5,6
Neprilysin cleaves beta amyloid into smaller, more soluble components that can
be removed from the brain. Estradiol also eliminates beta amyloid by multiple
mechanisms that I can discuss in a later blog.
Beta amyloid (the harmful protein) comes from the cleavage of amyloid
precursor protein (APP) by the enzyme beta
secretase. When APP is cleaved by an enzyme called alpha secretase, a harmless soluble form of amyloid—alpha amyloid—is made. Testosterone has
been shown to increase the production of alpha amyloid at the expense of
production of beta amyloid.8 To put it simply, testosterone reduces
the production of beta amyloid in the brain!
It’s important to realize also, why beta amyloid is associated with AD
– because it is directly toxic to brain cells. It suppresses their activity to
the point that they eventually just die. In addition to reducing beta amyloid
production and enhancing its removal, testosterone has been shown to directly protect
brain cells from the toxicity of beta amyloid. It does so by increasing the
production of a brain-protective protein called HS Protein 70.10
The second hallmark of AD is the formation of neurofibrillary tangles
(NFTs) from the collapse of a protein in brain cells called tau. Tau supports
the brain cell structurally, somewhat like the steel frame inside a commercial
building. When the tau collapses, the brain cell dies because it looses it’s
important structural integrity. Tau collapses and forms NFTs because it is cleaved by destructive enzymes. One
of these bad enzymes that cleaves the tau protein is called calpain. Testosterone
actually blocks the calpain enzyme, inhibiting NFT formation.9 In an
extension of this finding, the reduction in NFT formation by testosterone was
further confirmed to improve brain-cell survival.9
I’ve got to get back to my day job, now but I can tell you that the
evidence for protecting the brain from deterioration is no less impressive for
estradiol, progesterone, DHEA and melatonin. I’ll try to fill you in on these
later. The important point is that hormone depletion is related epidemiologically and biochemically to
AD. When those two types of evidence are combined the point is very difficult
to deny. Hormone replacement (HRT), then, becomes a very promising technique
for protecting the brain – something we’ve known at the Leonardi Institute for
some time now. And I can tell you our bioidentical HRT patients are thriving
physically and mentally, on par with people twenty to thirty years their
junior! All this and much more about AD is revealed in my and Dr. Nathan Daley’s
upcoming book: Alzheimer’s, Memory Loss,
MCI: The Latest Science for Prevention and Treatment, which should be
released sometime in May. More soon, I hope and a great day to all!
Dr. Dave Leonardi
References:
1. 1. Yaffe,
K., L. Y. Lui, J. Zmuda, and J. Cauley. 2002. Sex hormones and cognitive
function in older men. Journal of the
American Geriatrics Society 50 (4): 707–12.
2. 2. Barrett-Connor,
E., D. Goodman-Gruen, and B. Patay. 1999. Endogenous sex hormones and cognitive
function in older men. The Journal of
Clinical Endocrinology and Metabolism 84 (10): 3681–5.
3. 3. Cherrier,
M. M., A. M. Matsumoto, J. K. Amory, M. Johnson, S. Craft, E. R. Peskind, and
M. A. Raskind. 2007. Characterization of verbal and spatial memory changes from
moderate to supraphysiological increases in serum testosterone in healthy older
men. Psychoneuroendocrinology 32 (1):
72–9.
4. 4. Cherrier,
M. M., A. M. Matsumoto, J. K. Amory, S. Asthana, W. Bremner, E. R. Peskind, M.
A. Raskind, and S. Craft. 2005. Testosterone improves spatial memory in men
with Alzheimer disease and mild cognitive impairment. Neurology 64 (12): 2063–8.
5. 5. Yao , M., T. V. Nguyen, E.
R. Rosario, M. Ramsden, and C. J. Pike. 2008. Androgens regulate neprilysin
expression: Role in reducing beta-amyloid levels. Journal of Neurochemistry 105 (6): 2477–88.
6. 6. Yang, H. Q., Z. K. Sun, Q. H. Jiang, Q.
Shang, and J. Xu. 2009. [Effect of estrogen-depletion and 17beta-estradiol
replacement therapy upon rat hippocampus beta-amyloid generation]. Zhonghua Yi Xue Za Zhi
89 (37):
2658–61. [in Chinese].
7. 7. Gouras,
G. K., H. Xu, R. S. Gross, J. P. Greenfield, B. Hai, R. Wang, and P. Greengard.
2000. Testosterone reduces neuronal secretion of Alzheimer’s beta-amyloid
peptides. Proceedings of the National Academy of Sciences of the United States
of America 97 (3): 1202–5.
8. 8. Park,
S. Y., C. Tournell, R. C. Sinjoanu, and A. Ferreira. 2007. Caspase-3- and
calpain-mediated tau cleavage are differentially prevented by estrogen and
testosterone in beta-amyloid-treated hippocampal neurons. Neuroscience 144 (1): 119–27.
9. 9. Zhang,
Y., N. Champagne, L. K. Beitel, C. G. Goodyer, M. Trifiro, and A. LeBlanc.
2004. Estrogen and androgen protection of human neurons against intracellular
amyloid beta1-42 toxicity through heat shock protein 70. The Journal of
Neuroscience 24 (23):
5315–21.